Shanghai Institute Of Materia Medica Chinese Academy of Sciences;Suzhou Vigonvita Life Sciences Co., Ltd.;Topharman Shandong Co., Ltd.
发明人:
申请号：
EP15757771.9
公开号：
EP3115361A4
申请日:
2015.03.09
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Provided are heterocyclic compounds represented by formula (I), stereoisomers or pharmaceutically acceptable salts of said compounds, a pharmaceutical composition of said compounds, and an application of said compounds in the preparation of a drug for the prevention and/or treatment of a central nervous system disease.
